Preview

Diagnostic radiology and radiotherapy

Advanced search

Involvement of the central nervous system in patient with chronic inflammatory demyelinating polyneuropathy: a case report

https://doi.org/10.22328/2079-5343-2022-13-3-77-87

Abstract

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an uncommon disease characterized by heterogeneous clinical findings, absence of specific laboratory markers and good response to treatment. Typically CIDP manifests as weakness of varying severity, from minimal paresis to plegia, as well as symmetrical loss of sensitivity in all limbs, a distinctive clinical feature of CDL is the involvement of both proximal and distal parts of extremities. At the same time, there is a large number of atypical CIDP variants, clinically similar to other chronic disimmune neuropathies. Neuroimaging findings typically include involvement of the cauda equina, brachial, and lumbar plexus. The patient sought medical help complaining of weakness and loss of sensation in the extremities. This clinical case illustrates a combined involvement of cranial and spinal nerves, as well as spinal cord and brain in a patient with chronic inflammatory demyelinating polyneuropathy.

About the Authors

T. M. Rostovtseva
Federal center for brain and neurotechnologies of the Federal Medical and Biological Agency of Russian Federation
Russian Federation

Tatiana M. Rostovtseva — radiologist, research assistant of the department of radiologic and radionuclide diagnostic methods of the FCBN of the FMBA of Russian Federation; SPIN code 5840–7590.

117513, Moscow, Ostrovityanova str. 1, b.10



M. B. Dolgushin
Federal center for brain and neurotechnologies of the Federal Medical and Biological Agency of Russian Federation
Russian Federation

Mikhail B. Dolgushin — Dr. of Sci. (Med.), professor of the Russian Academy of Sciences, head of the department of radiologic and radionuclide diagnostic methods of the FCBN of the FMBA of Russian Federation; SPIN code 6388–9644.

117513, Moscow, Ostrovityanova str. 1, b. 10



A. V. Lopatina
Federal center for brain and neurotechnologies of the Federal Medical and Biological Agency of Russian Federation
Russian Federation

Anna V. Lopatina — neurologist of the FCBN of the FMBA of RF.

117513, Moscow, Ostrovityanova str. 1, b. 10



O. V. Boyko
Federal center for brain and neurotechnologies of the Federal Medical and Biological Agency of Russian Federation; Pirogov Russian National Research Medical University
Russian Federation

Olga V. Boyko — Dr. of. Sci. (Med.), head of the neurological department of the FCBN of the FMBA RF.

117513, Moscow, Ostrovityanova str. 1, b.10



E. A. Kovrazhkina
Federal center for brain and neurotechnologies of the Federal Medical and Biological Agency of Russian Federation
Russian Federation

Elena A. Kovrazhkina — Cand. of Sci. (Med.), senior research assistant of the scientific and research laboratory of clinical neurophysiology of the FCBN of the FMBA RF.

117513, Moscow, Ostrovityanova str. 1, b.10



S. A. Gulyaev
Federal center for brain and neurotechnologies of the Federal Medical and Biological Agency of Russian Federation
Russian Federation

Sergey A. Gulyaev — Dr. of Sci. (Med.), head of the scientific and research laboratory of clinical neurophysiology of the FCBN of the FMBA RF; SPIN code 6645–2922.

117513, Moscow, Ostrovityanova str. 1, b. 10



A. N. Boyko
Federal center for brain and neurotechnologies of the Federal Medical and Biological Agency of Russian Federation; Pirogov Russian National Research Medical University
Russian Federation

Alexey N. Boyko — Dr. of Sci. (Med.), professor, director of the institute of clinical neuroimmunology, head of the department of neuroimmunology of the FCBN of the FMBA RF; SPIN code 9921–9109.

117513, Moscow, Ostrovityanova str. 1, b. 10



References

1. Dyck P.J., Lais A.C., Ohta M., Bastron J.A., Okasaki H., Groover R.V. Chronic inflammatory polyradiculoneuropathy // Mayo Clin. Proc. 1975. Vol. 50. Р. 621–637.

2. Broers M.C., Bunschoten C., Nieboer D., Lingsma H.F., Jacobs B.C. Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis // Neuroepidemiology. 2019. Vol. 52, No. 3–4. Р. 161–172. doi: 10.1159/000494291.

3. Dalakas M.C. Advances in the diagnosis, pathogenesis and treatment of CIDP // Nat. Rev. Neurol. 2011. Vol. 7. Р. 507–517. doi: 10.1038/nrneurol.2011.121.

4. Ruth L., Drenthen J., Jacobs B.C., van Doorn P.A. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome // Neurology. 2010. Vol. 74. Р. 1680– 1686. doi: 10.1212/WNL.0b013e3181e07d14.

5. Vallat J.M., Sommer C., Magy L. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition // Lancet Neurol. 2010. Vol. 9. Р. 402–412. doi: 10.1016/S1474-4422(10)70041-7.

6. Members of the Task Force: P.Y.K. Van den Bergha, R.D.M. Haddenb, P. Bouchec, D.R. Cornblathd, A. Hahne, I. Illaf, C.L. Koskig, J.-M. Le´gerh, E. Nobile-Orazioi, J. Pollardj, C. Sommerk, P.A. van Doornl, van Schaikm I.N. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision // European Journal of Neurology. 2010. Vol. 17. Р. 356–363.

7. Athanasopoulos D., Motte J., Grüter T., Köse N., Yoon M.S., Otto S., Schneider-Gold C., Gold R., Fisse A.L., Pitarokoili K. Evaluation of the EFNS/PNS diagnostic criteria in a cohort of CIDP patients // Annals of clinical and translational neurology. 2021. Vol. 8, No. 5. Р. 1110–1121. doi: 10.1002/acn3.51357.

8. Sarova-Pinhas I., Achiron A., Gilad R., Lampl Y. Peripheral neuropathy in multiple sclerosis: a clinical and electrophysiologic study // Acta Neurol. Scand. 1995. Vol. 91. Р. 234–238. doi: 10.1111/j.1600-0404.1995.tb06996.x.

9. Hu B., Zhou Y., Lu X., Xiong Q., Liu Q., Qi X., Ding W. Chronic inflammatory demyelinating polyradiculoneuropathy: A case report // Medicine. 2018. Vol. 97, No. 41. e12469. doi: 10.1097/MD.0000000000012469.

10. Ormerod I.E., Waddy H.M., Kermode A.G., Murray N.M., Thomas P.K. Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study // Journal of neurology, neurosurgery, and psychiatry. 1990. Vol. 53, No. 9. Р. 789– 793. doi: 10.1136/jnnp.53.9.789.

11. Okumura A., Ushida H., Maruyama K., Itomi K., Ishiguro Y., Takahashi M., Osuga A., Negoro T., Watanabe K. Guillain-Barré syndrome associated with central nervous system lesions // Arch. Dis. Child. 2002. Apr 5. Vol. 86, No. 4. Р. 304–306. doi: 10.1136/adc.86.4.304. PMID: 11919115; PMCID: PMC1719164.

12. Sutter R., Mengiardi B., Lyrer P., Czaplinski A. Posterior reversible encephalopathy as the initial manifestation of a Guillain-Barré syndrome // Neuromuscul. Disord. 2009. Oct. Vol. 19, No. 10. Р. 709–710. doi: 10.1016/j.nmd.2009.06.370. Epub 2009 Jul 18. PMID: 19616949.

13. Mathey E.K., Park S.B., Hughes R.A.C., Pollard J.D., Armati P.J., Barnett M.H., Taylor B.V., Dyck P.J.B., Kiernan M.C., Lin C.S-Y. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype // Journal of Neurology, Neurosurgery & Psychiatry. 2015. Vol. 86. Р. 973–985. doi: 10.1136/jnnp2014-309697.

14. Reinhold A.K., Rittner H.L. Barrier function in the peripheral and central nervous system-a review // Pflugers. Arch. 2017. Vol. 469. Р. 123–134. doi: 10.1007/s00424-016-1920-8.

15. Kuwabara S., Nakajima M., Matsuda S., Hattori T. Magnetic resonance imaging at the demyelinative foci in chronic inflammatory demyelinating polyneuropathy // Neurology. 1997. Vol. 48. Р. 874–877. doi: 10.1212/WNL.48.4.874.

16. Laura М., Leong W., Murray N.M.F., Ingle G., Miszkiel K.A., Altmann D.R., Miller D.H., Reilly M.M. Chronic inflammatory demyelinating polyradiculoneuropathy: MRI study of brain and spinal cord // Neurology Mar. 2005. Vol. 64, No. 5. Р. 914–916. doi: 10.1212/01.WNL.0000152842.11864.D0.

17. Feasby Т.Е., Hahn A.F., Koopman W.J., Lee D.H. Central lesions in chronic inflammatory demyelinating polyneuropathy. An MRI study // Neurology Mar. 1990. Vol. 40, No. 3, Part 1. Р. 476. doi: 10.1212/WNL.40.3_Part_1.476.

18. Thompson A.J., Banwell B.L., Barkhof F., Carroll W.M., Coetzee Т., Comi G., Correale J., Fazekas F., Filippi М., Freedman M.S., Fujihara К., Galetta S.L., Hartung Н.Р., Kappos L., Lublin F.D., Marrie R.A., Miller А.Е., Miller D.H., Montalban Х., Mowry Е.М., Soelberg-Sorensen Р., Tintoré М., Traboulsee A.L., Trojano М., Uitdehaag B.M.J., Vukusic S., Waubant Е., Weinshenker B.G., Reingold S.C., Cohen J.A. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria // The Lancet Neurology. 2017. Vol. 17, No. 2. Р. 162–173. doi: 10.1016/S1474442(17)20470-2.


Review

For citations:


Rostovtseva T.M., Dolgushin M.B., Lopatina A.V., Boyko O.V., Kovrazhkina E.A., Gulyaev S.A., Boyko A.N. Involvement of the central nervous system in patient with chronic inflammatory demyelinating polyneuropathy: a case report. Diagnostic radiology and radiotherapy. 2022;13(3):77-87. (In Russ.) https://doi.org/10.22328/2079-5343-2022-13-3-77-87

Views: 635


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-5343 (Print)